Introduction
Healthy ageing has evolved from simply a desire to increase life expectancy, to more aspirational aims of avoiding disease, preserving physical functioning and allowing an independent engagement with life. Compelling evidence from meta-analyses and Cochrane reviews demonstrate the benefits of exercise, especially when physical activity (PA) is planned, structured and underpinned by the goal to improve or maintain physical fitness, performance and health for elderly people [1] . Exercise benefits for older people not only include prevention and treatment of increasingly prevalent chronic conditions, such as cardiovascular disease, but often more importantly, improvements in health-related quality of life [2] . The World Health Organisation [3] recommends a minimum average daily activity of 30 minutes at moderate-intensity, which can be achieved through walking (steps) and walking rapidly or uphill (steps/time). Free-living PA can be defined as a person's everyday physical activity in their usual environment, and for older, community-dwelling adults it is free-living PA which is crucial. The aims of PA in older people are to reduce sedentary behaviour, increase autonomy in daily activities and sustain long-term exercise goals, and as such these objectives are recommended to be achieved in older people's normal surroundings [4] .
Contemporary technology provides an unprecedented opportunity for the use of consumer-grade activity trackers (consumer wearables) to both understand, investigate and promote sustainable PA in older people. The measurement of PA is essential to all of these aims. The mainstay of measurement in older people has been self-report, and less often through the use of research-grade A C C E P T E D M A N U S C R I P T activity trackers. Self-report has inherent limitations, including the need to monitor duration and type of PA is being undertaken, as well as the capacity to recall specific aspects [5] . Often both these necessary attributes are flawed, leading to overestimation. Furthermore, self-report questionnaires have been criticised for the tendency to be age-or disease biased, excluding common elements of regular physical activity (e.g. personal care or domestic tasks), both potentially creating restrictions in accurate responses from older people. In contrast, research-grade motion sensors, which monitor activity such as pedometers, actometers and accelerometers, circumvent these issues by direct tracking [6] . Whilst these measurement devices are validated, they are often cumbersome and difficult to apply, therefore less useful in long-term monitoring of everyday PA in older communitydwelling adults, for either research requirements or personal motivation. Consequently, within the array of trackers, it is the consumer-grade physical activity trackers (e.g. Fitbit TM , Polar TM , Garmin TM , Apple Watch Sport TM ), which may become the preferred self-monitoring, measurement option.
Many studies to date have sought to validate the growing range of consumer-grade activity trackers, in both 'controlled' laboratory and 'free-living' environments [7, 8] , and with healthy and diseasespecific cohorts. Evenson et al (2015) [9] published the most recent systematic review on the validity of consumer wearables to monitor PA, and reported at the time of the search in 2014 only one study [4] had an older adult sample. Therefore, this systematic review aims to provide an update on prior evidence, with a specific focus on studies reporting the validity and reliability of consumer-grade activity trackers in older, community-dwelling adults.
Methods

Search Strategy
The review was guided by Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) [10] , with inclusion criteria and methods of analyses decided in advance. We performed a systematic search of three electronic databases MEDLINE, CINAHL and COCHRANE Central Register Figure 1 ) were undertaken. The eligibility of articles was independently assessed by two authors (NS, RG), and a third author (MA) made the decision when uncertainty occurred. Studies fulfilling the following criteria were included: (1) samples of community-dwelling adults (2) age >65 years, or having a sample mean age of >65 years, (3) measurement of step count with or without activity duration (time), using at least one consumer-grade activity tracker (wearable) (excluding pedometer only devices) and (4) the monitored period was in a 'free-living' or 'controlled' environment. Studies were excluded if the full-text was not available or published in a language other than English.
Data Extraction and Quality Assessment
Data was collected from eligible studies including, but not limited to, first author, publication year, location (country), sample size, age, proportion of female, chronic medical condition(s), consumergrade tracker used, placement, step count, activity duration (minutes or hours), monitoring period, reference measure, validity and reliability outcomes. The Critical Appraisal Skills Programme CASP (Cohort Study) Checklist was used to assess quality. On assessment, 75% of the studies met a minimum 80% of the evaluation criteria and therefore no paper was excluded on the basis of this quality assessment.
Data Analysis
For any extracted information that was missing from the publication, we made an attempt to contact at least one author to obtain the information. We tabulated our data, highlighting study
characteristics, consumer-grade activity tracker specifics, validity measures and comparative reliability of devices. Validity is reported on the basis of correlation coefficients (CC) and percentage error for agreement between devices or gold standard direct observation methodology (e.g. visual count). Reliability is reported as the mean differences or range (under or overestimation) of step count and activity duration versus similar validity comparators. In addition, we report activity monitor placement and the potential effects this had upon reliability of both devices.
Results
General characteristics of studies
The initial search identified 976 abstracts published since 2014, of which 956 were excluded; 20 papers had full-text assessment ( Figure 1 ). Further examination excluded 13 studies and the remaining 7 studies were included in the review. The total sample includes 290 participants with a mean age of 70.2±4.8 years and females constitute 46.7±26.1% (Table 1) . Studies were performed in Europe [14, 16] , Australia [11, 13] , UK [17] , US [15] and Canada [12] . Of the samples, one recruited participants during hospitalisation yet the primary monitoring period was measured in a free-living environment [16] , the remainder were community-dwelling adults. Two studies [13, 16] had samples diagnosed with coronary heart disease (CHD) and one [14] had sample of chronic obstructive pulmonary disease (COPD) patients. The remainder of the studies did not have specific diseasebased criteria.
Activity trackers and monitoring trends
In total, eight different consumer-grade activity trackers were included in this review ( [11, 15, 17] and alone [12, 13, 14, 16] .
Validity was assessed primarily against research-grade devices including ActiGraph TM , Bodymedia Sensewear TM , Shimmer3 TM and NL2000i TM , however two studies [11, 12] also used direct visual count as a comparator. Consumer-grade activity trackers were worn on the waist (50%), wrist (40%) and ankle (10%). Only two studies reported activity as overall duration [13, 14] , though seven of the eight consumer-grade trackers had the capability to do so. Five studies [11, 13, 14, 16, 17 ] required participants to monitor activity in their own free-living environments for a time period ranging from 3 to 28.2 days from placement. In two studies activity was monitored in controlled settings using pre-determined walking tracks and regulated gym conditions [12, 15] .
Validity of consumer-grade activity trackers (step count and activity time)
There was a high correlation in daily step count between the eight consumer-grade activity trackers and the reference research-grade trackers or study comparator (Table 3) , over a monitoring period > 24 hours in a free-living environment, in all but one study [16] . Validity was high versus ActiGraph Fitbit One TM , and Jawbone UP TM ) were accurate at measuring steps, in both non-impaired and impaired ambulation, older adults. Daily activity duration was also accurately captured by consumergrade devices compared to reference trackers, although at a lower correlation than for step counts 
Reliability of consumer-grade activity trackers (step count and activity time)
Daily step count was reported to be overestimated in the majority of cases, and regardless of device location ( versus research-grade devices [16, 17] . Lastly, compared to research-grade monitors, physical activity duration was overestimated [13] by the Fitbit Flex TM (average 10 min/day) and highly variable when measured with the Polar A300 TM device [14] .
Discussion
Our paper which includes an additional seven studies to the most recent systematic review [9] , provides further evidence contributing to the use of consumer wearables for the measurement of physical activity. To our knowledge this is the first systematic review to explore the validity and reliability of consumer-grade activity trackers for measuring step count and duration of PA in older, community-dwelling adults. Consumer wearables proved valid in the measurement of step count
and duration of PA when compared to research-grade activity trackers or visual (step-count) reference techniques. Slower walking speed and impaired ambulation reduced agreement. Most consumer-grade activity trackers overestimated step count, and to a lesser extent duration of PA.
Furthermore, in older people who have very slow walking speeds, careful consideration needs to be given to tracker selection. These are important finding given the growth in the use of consumergrade activity trackers to monitor and improve physical activity in health-care research and for independent use by consumers.
Validity and reliability of consumer-grade activity trackers in older adults
Tracking of free-living activity allows shared decision-making amongst patients and healthcare practitioners, when evaluating intervention need versus expected quality of life gains.
With the majority of consumer-grade activity trackers evaluated effectively capturing PA in older adults, future use may serve several research and interventional purposes requiring this accurate measurement. Such devices may be substituted for research-grade devices when evaluating interventions, prescribing PA and for self-monitoring by older people to manage their own activity levels. Physical functioning is imperative to allow seniors to engage fully and independently with their environment, especially as their complex care demands change. As such, consumer wearables may have particular benefit for older adults [18] .
As people age, many walk at a slower pace, experience uneven gait patterns and often require walking aids. It was at these reduced walking speeds or lower activity levels, that several studies [12, 13, 16] in this review reported greater percentage error or data acquisition difficulties, compared to validation devices and methods. Unfortunately, many individuals with chronic diseases, often experience common disease symptoms, such as breathlessness or fatigue (i.e. COPD or heart failure patients) and thus are prone to experience daily physical limitations [19] . In terms of device
placement, again there was disparity across trackers. For step count, compared to the wrist location, waist positioning appears to have less misrepresentation [16, 17] . Whereas for COPD patients [14] , activity duration monitoring varied significantly between the wrist-worn consumer wearable and the upper arm-worn validation monitor, potentially highlighting the sensitivity of the device components. Regardless of the variability, continuous wearing of both consumer or research-grade activity trackers, at the same location, provided the most accurate step count and activity duration results.
Nonetheless, it may be these individual level variables that may pose the greatest challenges ahead.
For instance, to date consumer wearables have been driven by the commercial development of fitness trackers, meaning that market guiding forces may limit capacity to influence development for use amongst older people [20] . Many consumer wearable algorithms are limited to recommended daily step counts or activity levels for that of healthy adults [21], potentially explaining the several measurement discrepancies observed in this review. In addition, as the use of consumer wearables grows, the complicated challenge of personal data management and security will become more apparent for patients and healthcare providers alike, an important yet unresolved matter.
Manufacturers will need to address these issues which underpin the expansion of consumer wearable populations.
Despite high accuracy of consumer-grade activity trackers compared to reference devices, reliability, was highly variable across devices in relation to agreement of steps taken per day. If we accept that the average daily step count for a community-dwelling older adult is around 7,500 steps/day [17] , over-or underrepresentation varied by as much as 30% in two separate studies [16, 17] between consumer and research-grade devices. Such variation means that the results from this study are difficult to apply to the wider, community-dwelling older adult population. Yet, it is important to acknowledge the physical activity data obtained by these consumer wearables was objective, and
recent studies have shown on average only 20% of adults aged 65-74 achieve 30mins of moderateintensity activity at least 5 days per week [22] . Therefore, such devices may have strong potential for older people to understand their own physical capabilities and increase self-efficacy towards personal and health-related goal achievement.
Older adults, comorbidities and physical activity
One of the important strategies to reduce aging-related morbidity is to increase physical activity among older people (Bauman et al. 2016) [23] . It was therefore encouraging to see that the overall mean age (70.2±4.8) of the sample in this review was sufficiently reflective of the aging population.
Also, three included studies [13, 14, 16] deliberately enrolled participants with chronic illnesses (cardiac and respiratory). This is important as it is within these groups of older adults that the greatest gains can be made from improved physical activity [24] . Yet despite the increasing number of studies on older adults in this review compared to the last [9] , the overall sample size was less than half, highlighting a gap in research being undertaken in this field for older adults. This underrepresentation means that current guidelines are often unable to provide comprehensive evidence-based information on the treatment of many chronic conditions [25].
Limitations
This review has several limitations. The literature on consumer-grade activity trackers is rapidly growing and it is therefore possible that studies were missed despite our best endeavors. Also, most studies had small samples and few had sample size calculations. The participants included in this review also represent a range of medical conditions, from acute clinical events to multiple chronic, long-term illnesses. How these different variables impact directly on step counts and physical activity time is not yet possible to predict. Several included studies reported issues with missing or
uninterpretable data across comparator devices and explanations from study investigators were not consistent, including altered positioning, low-intensity activity, loss of device and set-up error.
Importantly, the commercial imperative to improve updated marketable brands of wearable devices, means that several of the devices reported may no longer be in production and more recently launched devices may become redundant before testing is complete. Despite the limitations, this review is needed because of the increasing challenge for healthcare researchers to understand and measure physical activity across the rising number of older adults in their community-dwelling environments.
Conclusion
This systematic review included seven studies assessing validity and reliability of consumer-grade activity trackers for measuring physical activity through step counts and activity time in older, community-dwelling adults. Overall, the consumer-grade activity trackers were highly accurate for measuring average daily step count, and to a lesser extent, actual activity duration compared to research-grade reference devices. The review also highlighted issues that need to be addressed should the use consumer-grade activity trackers continue to grow, especially in relation to slow walking speeds, device positioning and gait. Nonetheless, this review provides supporting evidence and a more nuanced understanding for the use of consumer-grade activity trackers in the assessment of functional capacity in older adults.
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